Property | Value |
has minor subject area list
|
Adalimumab; Arthritis, Juvenile; Arthritis, Psoriatic; Arthritis, Rheumatoid; Crohn Disease; Global Health; Humans; Psoriasis; Spondylitis, Ankylosing
|
information resource reference
|
Adalimumab: long-term safety in 23 458 patients from global clinical trials in rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, psoriatic arthritis, psoriasis and Crohn's disease. Ann Rheum Dis. 2013 Apr; 72(4):517-24.
|
label
|
Adalimumab: long-term safety in 23 458 patients from global clinical trials in rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, psoriatic arthritis, psoriasis and Crohn's disease.
|